• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖异生在非胰岛素依赖型糖尿病患者肝脏葡萄糖生成增加中起主要作用。

Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

作者信息

Consoli A, Nurjhan N, Capani F, Gerich J

机构信息

Department of Medicine, University of Pittsburgh, School of Medicine, Pennsylvania.

出版信息

Diabetes. 1989 May;38(5):550-7. doi: 10.2337/diab.38.5.550.

DOI:10.2337/diab.38.5.550
PMID:2653926
Abstract

Excessive hepatic glucose output is an important factor in the fasting hyperglycemia of non-insulin-dependent diabetes mellitus (NIDDM). To determine the relative contributions of gluconeogenesis and glycogenolysis in a quantitative manner, we applied a new isotopic approach, using infusions of [6-3H]glucose and [2-14C]acetate to trace overall hepatic glucose output and phosphoenolpyruvate gluconeogenesis in 14 postabsorptive NIDDM subjects and in 9 nondiabetic volunteers of similar age and weight. Overall hepatic glucose output was increased nearly twofold in the NIDDM subjects (22.7 +/- 1.0 vs. 12.0 +/- 0.6 mumol.kg-1.min-1 in the nondiabetic volunteers, P less than .001); phosphoenolpyruvate gluconeogenesis was increased more than threefold in the NIDDM subjects (12.7 +/- 1.4 vs. 3.6 +/- 0.4 mumol.kg-1.min-1 in the nondiabetic subjects, P less than .001) and was accompanied by increased plasma lactate, alanine, and glucagon concentrations (all P less than .05). The increased phosphoenolpyruvate gluconeogenesis accounted for 89 +/- 6% of the increase in overall hepatic glucose output in the NIDDM subjects and was significantly correlated with the fasting plasma glucose concentrations (r = .67, P less than .01). Glycogenolysis, calculated as the difference between overall hepatic glucose output and phosphoenolpyruvate gluconeogenesis, was not significantly different in the NIDDM subjects (9.9 +/- 0.06 mumol.kg-1.min-1) and the nondiabetic volunteers (8.4 +/- 0.3 mumol.kg-1.min-1). We conclude that increased gluconeogenesis is the predominant mechanism responsible for increased hepatic glucose output in NIDDM.

摘要

肝脏葡萄糖输出过多是非胰岛素依赖型糖尿病(NIDDM)空腹高血糖的一个重要因素。为了定量确定糖异生和糖原分解的相对贡献,我们应用了一种新的同位素方法,通过输注[6-³H]葡萄糖和[2-¹⁴C]乙酸盐来追踪14名吸收后NIDDM患者以及9名年龄和体重相近的非糖尿病志愿者的肝脏葡萄糖总输出量和磷酸烯醇丙酮酸糖异生情况。NIDDM患者的肝脏葡萄糖总输出量增加了近两倍(非糖尿病志愿者为12.0±0.6μmol·kg⁻¹·min⁻¹,NIDDM患者为22.7±1.0μmol·kg⁻¹·min⁻¹,P<0.001);NIDDM患者的磷酸烯醇丙酮酸糖异生增加了三倍多(非糖尿病患者为3.6±0.4μmol·kg⁻¹·min⁻¹,NIDDM患者为12.7±1.4μmol·kg⁻¹·min⁻¹,P<0.001),同时伴有血浆乳酸、丙氨酸和胰高血糖素浓度升高(均P<0.05)。在NIDDM患者中,磷酸烯醇丙酮酸糖异生增加量占肝脏葡萄糖总输出量增加量的89±6%,且与空腹血糖浓度显著相关(r = 0.67,P<0.01)。通过计算肝脏葡萄糖总输出量与磷酸烯醇丙酮酸糖异生之间的差值得出的糖原分解量,在NIDDM患者(9.9±0.06μmol·kg⁻¹·min⁻¹)和非糖尿病志愿者(8.4±0.3μmol·kg⁻¹·min⁻¹)之间无显著差异。我们得出结论,糖异生增加是NIDDM患者肝脏葡萄糖输出增加的主要机制。

相似文献

1
Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.糖异生在非胰岛素依赖型糖尿病患者肝脏葡萄糖生成增加中起主要作用。
Diabetes. 1989 May;38(5):550-7. doi: 10.2337/diab.38.5.550.
2
Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.非胰岛素依赖型糖尿病中糖异生增加的机制。全身、肝脏及肌肉中乳酸和丙氨酸代谢改变的作用。
J Clin Invest. 1990 Dec;86(6):2038-45. doi: 10.1172/JCI114940.
3
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.底物诱导的糖异生未能增加正常人的总体葡萄糖生成。证明了肝脏的自动调节且血浆葡萄糖浓度无变化。
J Clin Invest. 1990 Aug;86(2):489-97. doi: 10.1172/JCI114735.
4
Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.非胰岛素依赖型糖尿病中脂解作用增强及其对糖异生的影响
J Clin Invest. 1992 Jan;89(1):169-75. doi: 10.1172/JCI115558.
5
Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.非胰岛素依赖型糖尿病患者禁食3天后糖异生的抑制不会耗尽肝糖原。
Diabetes. 1994 Feb;43(2):256-62. doi: 10.2337/diab.43.2.256.
6
Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.非胰岛素依赖型糖尿病中异常肌肉和肝脏葡萄糖代谢对餐后高血糖的作用。
Diabetes. 1990 Nov;39(11):1381-90. doi: 10.2337/diab.39.11.1381.
7
Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.非胰岛素依赖型糖尿病患者在禁食3天后肝脏糖原增加的证据。
J Clin Endocrinol Metab. 1992 Mar;74(3):660-6. doi: 10.1210/jcem.74.3.1740502.
8
Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man.体内三羧酸循环代谢碳交换的测定及其用于估算糖异生和糖原分解对人体整体葡萄糖输出的个体贡献。
J Clin Invest. 1987 Nov;80(5):1303-10. doi: 10.1172/JCI113206.
9
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.二甲双胍对非胰岛素依赖型糖尿病患者葡萄糖及乳酸代谢的代谢作用
J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67. doi: 10.1210/jcem.81.11.8923861.
10
Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.正常受试者和中度高血糖非胰岛素依赖型糖尿病(NIDDM)受试者肝脏中间代谢的无创追踪。反对NIDDM中糖异生增加和肝脏脂肪酸氧化增加的证据。
Diabetologia. 1998 Feb;41(2):212-20. doi: 10.1007/s001250050892.

引用本文的文献

1
[Not Available].[无可用内容]
Tunis Med. 2024 Apr 5;102(4):235-240. doi: 10.62438/tunismed.v102i4.4629.
2
Dietary intakes of methionine, threonine, lysine, arginine and histidine increased risk of type 2 diabetes in Chinese population: does the mediation effect of obesity exist?膳食中蛋氨酸、苏氨酸、赖氨酸、精氨酸和组氨酸的摄入量增加了中国人患 2 型糖尿病的风险:肥胖是否存在中介效应?
BMC Public Health. 2023 Aug 15;23(1):1551. doi: 10.1186/s12889-023-16468-z.
3
Liver or kidney: Who has the oar in the gluconeogenesis boat and when?肝脏还是肾脏:在糖异生过程中谁起着关键作用,何时起作用?
World J Diabetes. 2023 Jul 15;14(7):1049-1056. doi: 10.4239/wjd.v14.i7.1049.
4
Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases.旧瓶装新酒:穿心莲内酯在动脉粥样硬化性心血管疾病中的预防和治疗潜力
J Pharm Anal. 2023 Jun;13(6):563-589. doi: 10.1016/j.jpha.2023.05.010. Epub 2023 May 20.
5
Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training.通过食用染料木黄酮和运动训练相结合减轻高脂高蔗糖-果糖喂养小鼠的MAFLD
Diabetes Metab Syndr Obes. 2022 Jul 23;15:2157-2172. doi: 10.2147/DMSO.S358256. eCollection 2022.
6
A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex.一种源于蜂胶的小分子通过靶向 CREB/CRTC2 转录复合物改善肥胖小鼠的代谢综合征。
Nat Commun. 2022 Jan 11;13(1):246. doi: 10.1038/s41467-021-27533-9.
7
The hepatic compensatory response to elevated systemic sulfide promotes diabetes.肝脏对升高的系统性硫化物的代偿反应促进糖尿病。
Cell Rep. 2021 Nov 9;37(6):109958. doi: 10.1016/j.celrep.2021.109958.
8
Structure-Activity Relationship and Biological Investigation of SR18292 (), a Suppressor of Glucagon-Induced Glucose Production.结构-活性关系及 SR18292()的生物学研究,一种胰高血糖素诱导的葡萄糖产生的抑制剂。
J Med Chem. 2021 Jan 28;64(2):980-990. doi: 10.1021/acs.jmedchem.0c01450. Epub 2021 Jan 12.
9
Predictive equations for evaluation for resting energy expenditure in Brazilian patients with type 2 diabetes: what can we use?用于评估巴西2型糖尿病患者静息能量消耗的预测方程:我们能用什么?
BMC Nutr. 2020 Sep 30;6:56. doi: 10.1186/s40795-020-00384-1. eCollection 2020.
10
Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives.2 型糖尿病管理:当前策略、未聚焦方面、挑战和替代方案。
Med Princ Pract. 2021;30(2):109-121. doi: 10.1159/000511002. Epub 2020 Aug 20.